This is a Cost Plus Fixed Fee contract awarded by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate to Silver Lake Research Corporation, a small business, for research and development services related to the generation, validation, and characterization of new monoclonal antibodies reactive with a group of toxins. The contract has a ceiling value of $1,167,200.00 and an ultimate completion date of December 31, 2019. This award does not have a set-aside designation....
This is a Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Silver Lake Research Corporation, a small business manufacturer of rapid testing innovations. The $466,200 Firm Fixed Price contract is for the development of "HYPERSPECIFIC MONOCLONAL ANTIBODIES AND LATERAL FLOW ASSAYS" and does not have a set-aside designation. Silver Lake Research Corporation is also the recipient of prime federal contracts and grants from agencies such as the National...
This is a $599,999.40 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Silver Lake Research Corporation, doing business as Silver Lake Research Corp. The contract is for the development of EAP-derived monoclonal antibodies for phenotyping immune cells of animal models of disease. This work supports infectious disease research and response programs. The contract does not have a...
Silver Lake Research Corporation, doing business as Silver Lake Research Corp., has been awarded a firm fixed price definitive contract valued at $600,000 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, Silver Lake will deliver EAP-derived monoclonal antibodies for immune targets involved in cell activation in hamsters, as requested in the original solicitation. The prime contractor will perform work in Irwindale, California....
This $600,000 firm fixed price contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Silver Lake Research Corporation, doing business as Silver Lake Research Corp., for EAP-derived monoclonal antibodies for phenotyping guinea pig immune cells under Phase I of the Small Business Innovation Research (SBIR) program for fiscal year 2020. As a total small business set-aside, the contract supports Silver Lake's research and development...
This $1,549,750.63 federal contract was awarded by the Department of Homeland Security (DHS) Science and Technology (S&T) Directorate to Gate Scientific, Inc., a for-profit manufacturer of goods based in Milpitas, California. The contract is for the development of an "Instrumentless Molecular Testing Platform for Foreign Animal Disease Testing" and is not subject to a small business set-aside. The contract was awarded under a Broad Agency Announcement (BAA) issued by DHS S&T,...
This is a $24,617.45 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to Meso Scale Diagnostics LLC, a for-profit limited liability company. The contract is for screening monoclonal antibodies against proteins of interest, with a period of performance through July 31, 2024. No small business set-aside was used. Meso Scale Diagnostics is an...
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Research And Diagnostic Systems, Inc. (R&D Systems), a for-profit manufacturer of research materials including proteins, antibodies, and ELISA kits. The contract, valued at $6,608.20, is for the delivery of Human ELISA Kits. The contract is a Firm Fixed Price Purchase Order with a completion date of June 29, 2018. The...
This is a $566,274.26 firm-fixed-price definitive contract awarded by the Department of Homeland Security (DHS) Science and Technology Directorate to EcoHealth Alliance Inc., a non-profit organization. The contract, titled "RAPID EVALUATION OF PATHOGENS TO PREVENT EPIDEMICS IN LIVESTOCK (REPEL) PROJECT TO APPLY BIOLOGICAL-BASED, PATHOGEN AGNOSTIC MEDICAL COUNTERMEASURE VACCINE AND DIAGNOSTIC PLATFORMS TO DEVELOP FOREIGN ANIMAL AND EMERGING ZOONOTIC LIVESTOCK DISEASE VAC", was awarded...
The U.S. Defense Health Agency awarded a $34,225 firm-fixed-price delivery order contract to Leinco Technologies, Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract is for the provision of monoclonal antibodies from knockout mice that have been in-vivo genetically immunized with interferon-alpha/beta receptor alpha chain protein. This contract award supports federal research initiatives related to COVID-19 and other viral pathogens. Leinco Technologies...